1. Polymers and Polymeric Materials in COVID-19 Pandemic: A Review
2. Looking beyond COVID-19 vaccine phase 3 trials
3. Cohan, P. Moderna Covid-19 Vaccine Could Add Nearly $35 Billion To Its Revenues. Forbes, Nov 16, 2020; www.forbes.com/sites/petercohan/2020/11/16/moderna-covid-19-vaccine-could-add-nearly-35-billion-to-its-revenues (accessed 2021-02-05).
4. Jennings, K.; Rosenbaum, L. Pfizer, BioNTech Boost Vaccine Production Goal To 2 Billion Doses In 2021. Forbes, Jan 12, 2021; www.forbes.com/sites/katiejennings/2021/01/12/pfizer-biontech-boost-vaccine-production-goal-to-2-billion-doses-in-2021 (accessed 2021-02-05).
5. Sequence-Controlled Polymers